Nicolas Van de Velde

机构：Moderna Therapeutics (United States) · ORCID：0000-0003-4358-5873

发表论文 107 篇 · 总被引 1998 次 · h-index 21

代表论文

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE (2025 · Advances in Therapy · 被引 15)
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2024 vaccines in the United Kingdom (2024 · Journal of Medical Economics · 被引 10)
Healthcare Resource Utilization (HCRU) and Direct Medical Costs Associated with Long COVID or Post-COVID-19 Conditions: Findings from a Literature Review (2025 · Journal of Market Access & Health Policy · 被引 9)
The potential impact of the next-generation COVID-19 mRNA-1283 vaccine in Canada (2025 · Journal of Medical Economics · 被引 7)
Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States (2025 · Infectious Diseases and Therapy · 被引 5)
Comparative Effectiveness of the mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults With Underlying Medical Conditions: A Systematic Literature Review and Pairwise Meta-Analysis Using GRADE (2024 · medRxiv · 被引 4)